Clinical Trial Update: Long Term Safety Of GW685698X Via Nasal Biopsy [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting long-term safety data for GW685698X administered via nasal biopsy in allergic rhinitis (perennial).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• GW685698X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED